Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (8): 849-851.DOI: 10.3969/j.issn.1673-8640.2020.08.024
Previous Articles Next Articles
Received:
2019-11-02
Online:
2020-08-30
Published:
2020-09-24
CLC Number:
. [J]. Laboratory Medicine, 2020, 35(8): 849-851.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.08.024
[1] | SIMERVILLE J A,MAXTED W C,PAHIRA J J. Urinalysis:a comprehensive review[J]. Am Fam Physician,2005,71(6):1153-1162. |
[2] | 王加,王珏. 非浓缩尿蛋白电泳在原发性高血压肾损伤中的应用评价[J]. 标记免疫分析与临床,2018,25(1):126-129. |
[3] | LOPEZ M F,BERGGREN K,CHERNOKALSKAYA E,et al. A comparison of silver stain and SYPRO ruby protein gel stain with respect to protein detection in two-dimension gels and identification by peptide mass profiling[J]. Electrophoresis,2000,21:3673-3683. |
[4] | 崔艳丽,王生余,张真. 微波技术在尿蛋白谱检测中的应用[J]. 现代检验医学杂志,2002,17(4):35-36. |
[5] | MUCHMORE A V,DECKER J M. Uromodulin:a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women[J]. Science,1985,229(4712):479-481. |
[6] | GARIMELLA P S,SARNAK M J. Uromodulin in kidney health and disease[J]. Curr Opin Nephrol Hypertens,2017,26(2):136-142. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||